Friday, April 4, 2025
The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Perspectives
Health Policy
Health Equity
Research
New Approvals
Menu
FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer
May 16, 2024
The FDA approves a new drug for HER2-positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1
March 21, 2025
